Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1989;13:766-772

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pettinger, W. A.
Right arrow Articles by Mitchell, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pettinger, W. A.
Right arrow Articles by Mitchell, H. C.

Hypertension, Vol 13, 766-772, Copyright © 1989 by American Heart Association


ARTICLES

Long-term improvement in renal function after short-term strict blood pressure control in hypertensive nephrosclerosis

WA Pettinger, HC Lee, J Reisch and HC Mitchell
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.

Seventy-nine hypertensive nephrosclerosis patients entered a prospective randomized single-blind study to 1) establish the pattern of decay of renal function in this population and the variability therein and 2) to determine if strict diastolic blood pressure (DBP) control (less than or equal to 80 mm Hg) is more effective than conventional levels (90-95 mm Hg) in conserving renal function. Because of unexpected significant improvement in renal function in patients from both groups, which changed the perspectives on the course of this disease as described herein, this report is being published before completion of the trial. The selection criteria were 1) serum creatinine concentration of 1.6-7.0 mg/dl, 2) glomerular filtration rate of less than 70 ml/min/1.73 m2, and 3) absence of diseases (other than hypertension) known to destroy renal function. Renal function was assessed by glomerular filtration rate [( 125I]iothalamate clearance) and serum creatinine concentration. Before randomization, DBP was aggressively treated to reduce it to less than 80 mm Hg. Twenty-two subjects (14 in the strict DBP control group and eight in the conventional DBP control group) have been enrolled in the study for 36 months. In contrast to results from previous studies in humans and rats, renal function improved in both patient groups. Thus, irrevocable progression of renal damage after onset of renal failure from high blood pressure does not necessarily occur, and in fact, long-term improvement of renal function resulted from the effects of the study itself.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
HypertensionHome page
A. Shankar, R. Klein, B. E.K. Klein, F. J. Nieto, and S. E. Moss
Relationship Between Low-Normal Blood Pressure and Kidney Disease in Type 1 Diabetes
Hypertension, January 1, 2007; 49(1): 48 - 54.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
J. A. Jaffe and P. L. Kimmel
Chronic Nephropathies of Cocaine and Heroin Abuse: A Critical Review
Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 655 - 667.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. A. Moore, M. Epstein, L. Agodoa, and L. D. Dworkin
Current Strategies for Management of Hypertensive Renal Disease
Arch Intern Med, January 11, 1999; 159(1): 23 - 28.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
National High Blood Pressure Education Program Wor
1995 Update of the Working Group Reports on Chronic Renal Failure and Renovascular Hypertension
Arch Intern Med, September 23, 1996; 156(17): 1938 - 1947.
[Abstract] [PDF]


Home page
NEJMHome page
M. J. Klag, P. K. Whelton, B. L. Randall, J. D. Neaton, F. L. Brancati, C. E. Ford, N. B. Shulman, and J. Stamler
Blood Pressure and End-Stage Renal Disease in Men
N. Engl. J. Med., January 4, 1996; 334(1): 13 - 18.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
N. K. Hollenberg and L. Raij
Angiotensin-Converting Enzyme Inhibition and Renal Protection: An Assessment of Implications for Therapy
Arch Intern Med, November 8, 1993; 153(21): 2426 - 2435.
[Abstract] [PDF]


Home page
NEJMHome page
G. D. Johnston, W. A. Pettinger, H.-C. Lee, B. Z. Paulshock, B. J. Materson, D. J. Reda, W. C. Cushman, and C. F. Rouse
Single-Drug Therapy for Hypertension in Men
N. Engl. J. Med., September 30, 1993; 329(14): 1043 - 1045.
[Full Text]


Home page
JAMAHome page
T. V. Perneger, F. J. Nieto, P. K. Whelton, M. J. Klag, G. W. Comstock, and M. Szklo
A Prospective Study of Blood Pressure and Serum Creatinine: Results From the 'Clue' Study and the ARIC Study
JAMA, January 27, 1993; 269(4): 488 - 493.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
R. L. Koretz
Studies within Studies
Ann Intern Med, April 15, 1992; 116(8): 698 - 698.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
R. D. Toto, H. C. Mitchell, H.-C. Lee, C. Milam, and W. A. Pettinger
Reversible Renal Insufficiency due to Angiotensin Converting Enzyme Inhibitors in Hypertensive Nephrosclerosis
Ann Intern Med, October 1, 1991; 115(7): 513 - 519.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
National High Blood Pressure Education Program
National High Blood Pressure Education Program Working Group Report on Hypertension and Chronic Renal Failure
Arch Intern Med, July 1, 1991; 151(7): 1280 - 1287.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
S. J. Rosansky, D. R. Hoover, L. King, and J. Gibson
The Association of Blood Pressure Levels and Change in Renal Function in Hypertensive and Nonhypertensive Subjects
Arch Intern Med, October 1, 1990; 150(10): 2073 - 2076.
[Abstract] [PDF]